Sign in
FTRE Stock Price, Chart, Stats & News
Fortrea Holdings Inc.
Save
1.61B
Market cap
30.39x
Current P/E
12.15x
Forward P/E
FTRE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 16.35% |
Operating margin | -19.76% |
Pretax margin | -36.09% |
Net margin | -36.21% |
Effective tax rate | -0.33% |
ROA | -36.31% |
ROE | -152.17% |
D/E | 0.12x |
Interest coverage ratio | -5.89x |
FTRE valuation
P/E | 30.39x |
P/S | 0.31x |
P/B | 1.47x |
P/CF | 7.29x |
P/FCF | 9.60x |
P/OCF | 7.29x |
PEG | -0.30x |
EV multiple | -1.17x |
About
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development.
Similar securities
Based on sector and market capitalization
Report issue